Inactive Instrument

News Auspex Pharmaceuticals Inc

Equities

US05211J1025

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2015	Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions	RE
2015	Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions	15-04-22	RE
Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal	15-04-22	RE
Auspex Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Auspex Pharmaceuticals, Inc.	15-03-31	PR
Auspex Pharmaceuticals : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Auspex Pharmaceuticals, Inc. Stockholders	15-03-30	BU
Stocks rally on merger activity; dollar gains	15-03-30	RE
Stocks rally on merger activity; dollar gains	15-03-30	RE
FUJIFILM : Wall St. rebounds from recent losses; deals help	15-03-30	RE
Auspex Pharmaceuticals : Pharma Stockholders Encouraged to Contact Securities Law Firm about Takeover	15-03-30	PR
Auspex Pharmaceuticals : Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion	15-03-30	RE
Results of Auspex Pharmaceuticals' Phase 3 Registration Trial of SD-809 to be Presented at AAN Annual Meeting	15-03-27	GL
Auspex Pharmaceuticals Reports Fourth Quarter 2014 Results and Business Highlights	15-03-16	GL
Auspex Pharmaceuticals : to Present at the Cowen Healthcare Conference	15-02-28	PU
Auspex to Present at the Cowen Healthcare Conference	15-02-23	GL
Auspex Pharmaceuticals Completes Enrollment in a Pivotal Clinical Trial of SD-809 in Tardive Dyskinesia	15-02-03	GL
Auspex Announces Pricing of Follow on Offering	15-01-23	GL
Auspex Announces Proposed Public Offering of Common Stock	15-01-21	GL
Auspex Pharmaceuticals Announces SD-1077 Program for the Potential Treatment of Parkinson's Disease and Related Movement Disorders	15-01-12	GL
Auspex Announces Favorable Topline Results From Thorough QT Clinical Trial of SD-809	15-01-12	GL
Auspex to Present at the J.P. Morgan Healthcare Conference	15-01-05	GL
Auspex Added to the NASDAQ Biotechnology Index	14-12-22	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Auspex Pharmaceuticals Inc

Equities

US05211J1025

Summary

Filters